Oct 1 (Reuters) - Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer and its CEO, Albert ...

Florida Attorney General James Uthmeier has sued Pfizer (PFE), accusing the company and its CEO, Albert Bourla, of marketing its COVID-19 vaccine as safe when there were allegedly serious health ...

Florida Attorney General James Uthmeier filed a lawsuit Thursday against Pfizer Inc., alleging unfair and deceptive marketing of Pfizer’s COVID-19 vaccine. The suit, filed in state trial court in St.

Learn more Pfizer (PFE) is facing a lawsuit filed by Florida Attorney General James Uthmeier alleging deceptive marketing practices related to COVID-19 vaccines, the attorney general's office said ...

The pharmaceutical giant sent shareholders a torrent of cash, yet the stock itself went backward. Here is the accounting of ...

(NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-t ...

Both face patent cliffs and pay generous dividends, but only one of them can tell you where its next wave of growth is coming ...

Pfizer faces some major LoE headwinds, but the stock is cheap and offers a large dividend, offering a solid total return ...

The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.

Income investors shouldn't be too worried about the pharma giant cutting its dividend.

A federal judge in Delaware on Monday rejected Pfizer , BioNTech and Moderna's requests ​to dismiss patent lawsuits filed ...

Phase 2 results showing that tilrekimig achieved significant improvements in skin clearance in adults with moderate-to-severe atopic dermatitis, sup ...